BT
NVAX icon

Banque Transatlantique’s Novavax NVAX Stock Holding History

Banque Transatlantique’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784 Hold
120
– – ﹤0.01% 488
2026
Q1 		$985 Hold
120
– – ﹤0.01% 427
2025
Q4 		$806 Hold
120
– – ﹤0.01% 253
2025
Q3 		$1.04K Hold
120
– – ﹤0.01% 252
2025
Q2 		$760 Hold
120
– – ﹤0.01% 237
2025
Q1 		$769 Hold
120
– – ﹤0.01% 222
2024
Q4 		$959 Buy
+120
New +$1.16K ﹤0.01% 254

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Banque Transatlantique's NVAX Position: Q2 2026 in Review

Banque Transatlantique held its Novavax (NVAX) position steady in Q2 2026 at 120 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #488.

Banque Transatlantique first reported a position in NVAX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.04K in Q3 2025. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Banque Transatlantique held 120 shares of Novavax worth $784 as of Q2 2026.
  • Banque Transatlantique left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Banque Transatlantique's portfolio in Q2 2026, its #488 holding.
  • Banque Transatlantique first reported a position in Novavax in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Novavax position peaked at $1.04K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.